How AI and High-Throughput Screening Are Shaping the Cell Viability Assays Market According to a newly published market research report by 24LifeSciences, the global cell viability assays market value is at USD 2.58 billion in 2026 and is projected to reach USD 3.64 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period. Cell viability assays are essential laboratory techniques used to determine the proportion of living, healthy cells within a population. These assays function by measuring vital indicators such as metabolic activity, membrane integrity, and ATP content, which act as reliable proxies for cell health and function. Their application is fundamental across drug discovery, basic biomedical research, toxicology studies, and cancer research, providing critical data on how cells respond to new drug compounds, environmental toxins, or other experimental conditions. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/8987/cell-viability-assays-market

Oligonucleotide Pool Market Size to Reach USD 2.27 Billion by 2032 Global oligonucleotide pool market is experiencing strong momentum as genomics, synthetic biology, and next-generation therapeutics continue to reshape life sciences research. Valued at USD 1.25 billion in 2024, the market is projected to grow from USD 1.36 billion in 2025 to USD 2.27 billion by 2032, registering a robust compound annual growth rate (CAGR) of 9.1% during the forecast period. This expansion reflects accelerating investment in genomic research, growing adoption of high-throughput screening technologies, and rising demand for precision-designed oligonucleotide libraries across research and therapeutic development. Access the market report https://www.24lifesciences.com/oligonucleotide-pool-market-9559